Ad is loading...
BLFS
Price
$25.01
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
112 days until earnings call
ESTA
Price
$41.81
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
103 days until earnings call
Ad is loading...

BLFS vs ESTA

Header iconBLFS vs ESTA Comparison
Open Charts BLFS vs ESTABanner chart's image
BioLife Solutions
Price$25.01
Change-$0.00 (-0.00%)
Volume$926.54K
CapitalizationN/A
Establishment Labs Holdings
Price$41.81
Change-$0.00 (-0.00%)
Volume$1M
CapitalizationN/A
BLFS vs ESTA Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ESTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BLFS vs. ESTA commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and ESTA is a Hold.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (BLFS: $25.01 vs. ESTA: $41.81)
Brand notoriety: BLFS and ESTA are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 225% vs. ESTA: 190%
Market capitalization -- BLFS: $810.87M vs. ESTA: $1.33B
BLFS [@Medical Specialties] is valued at $810.87M. ESTA’s [@Medical Specialties] market capitalization is $1.33B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileESTA’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • ESTA’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than ESTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 6 TA indicator(s) are bullish while ESTA’s TA Score has 5 bullish TA indicator(s).

  • BLFS’s TA Score: 6 bullish, 4 bearish.
  • ESTA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BLFS is a better buy in the short-term than ESTA.

Price Growth

BLFS (@Medical Specialties) experienced а +3.73% price change this week, while ESTA (@Medical Specialties) price change was +6.33% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.03%. For the same industry, the average monthly price growth was -1.56%, and the average quarterly price growth was -3.39%.

Reported Earning Dates

BLFS is expected to report earnings on Mar 13, 2025.

ESTA is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Medical Specialties (+0.03% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESTA($1.33B) has a higher market cap than BLFS($811M). ESTA YTD gains are higher at: 61.491 vs. BLFS (53.908). BLFS has higher annual earnings (EBITDA): -45.24M vs. ESTA (-58.31M). BLFS has more cash in the bank: 51.7M vs. ESTA (40M). BLFS has less debt than ESTA: BLFS (42.7M) vs ESTA (192M). ESTA has higher revenues than BLFS: ESTA (165M) vs BLFS (143M).
BLFSESTABLFS / ESTA
Capitalization811M1.33B61%
EBITDA-45.24M-58.31M78%
Gain YTD53.90861.49188%
P/E Ratio238.10N/A-
Revenue143M165M87%
Total Cash51.7M40M129%
Total Debt42.7M192M22%
FUNDAMENTALS RATINGS
BLFS vs ESTA: Fundamental Ratings
BLFS
ESTA
OUTLOOK RATING
1..100
5972
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
8265
SMR RATING
1..100
9399
PRICE GROWTH RATING
1..100
5060
P/E GROWTH RATING
1..100
20100
SEASONALITY SCORE
1..100
n/a29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESTA's Valuation (66) in the Medical Specialties industry is in the same range as BLFS (95). This means that ESTA’s stock grew similarly to BLFS’s over the last 12 months.

ESTA's Profit vs Risk Rating (65) in the Medical Specialties industry is in the same range as BLFS (82). This means that ESTA’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's SMR Rating (93) in the Medical Specialties industry is in the same range as ESTA (99). This means that BLFS’s stock grew similarly to ESTA’s over the last 12 months.

BLFS's Price Growth Rating (50) in the Medical Specialties industry is in the same range as ESTA (60). This means that BLFS’s stock grew similarly to ESTA’s over the last 12 months.

BLFS's P/E Growth Rating (20) in the Medical Specialties industry is significantly better than the same rating for ESTA (100). This means that BLFS’s stock grew significantly faster than ESTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSESTA
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ESTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGIRX58.070.02
+0.03%
Hartford Core Equity R3
FMXSX8.44N/A
N/A
Federated Hermes Max-Cap Index Svc
MTCBX51.51N/A
N/A
MFS Technology B
NFAAX30.40N/A
N/A
Neuberger Berman Focus A
GUMCX25.97-0.01
-0.04%
NAA Market Neutral Real Estate C

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with AZTA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+11.45%
AZTA - BLFS
53%
Loosely correlated
+9.14%
VCYT - BLFS
50%
Loosely correlated
+0.13%
MASS - BLFS
48%
Loosely correlated
+3.23%
RGEN - BLFS
47%
Loosely correlated
+8.10%
TWST - BLFS
44%
Loosely correlated
-0.51%
More